GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is rapidly gaining a significant focus in healthcare studies, largely due to its remarkable impact on treating diseases such as type 2 diabetes and excess body fat. Recent research have revealed that beyond glucose management, GLP-1 agonists offer potential for heart well-being and even br